-
A program of exercise, brain training, and lecture to prevent cognitive decline. Ann Clin Transl Neurol 2020; doi: 10.1002/acn3.50993.
Kouzuki M, Kato T, Wada-Isoe K, Takeda S, Tamura A, Takanashi Y, Azumi S, Kojima Y, Maruyama C, Hayashi M, Itou M, Urakami K.
-
Evaluation of the effect of aroma oil as a bath salt on cognitive function. Psychogeriatrics 2020; 20(2): 163-171.
Kouzuki M, Kitao S, Kaju T, Urakami K.
-
Post-fracture Rehabilitation Effects on Brain Function in Older People. Yonago Acta Med 2019; 62(1): 62-66.
Mitsuboshi N, Kouzuki M, Kobayashi Y, Tanaka M, Asada T, Morimoto K, Urakami K.
-
Effect of monosodium L-glutamate (umami substance) on cognitive function in people with dementia. Eur J Clin Nutr 2019; 73(2): 266-275.
Kouzuki M, Taniguchi M, Suzuki T, Nagano M, Nakamura S, Katsumata Y, Matsumoto H, Urakami K.
-
123I-MIBG myocardial scintigraphy for the diagnosis of DLB: a multicentre 3-year follow-up study. J Neurol Neurosurg Psychiatry 2018; 89(11): 1167-1173.
Komatsu J, Samuraki M, Nakajima K, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakamura H, Nakano S, Nakashima K, Nishio Y, Orimo S, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamashina S, Yamasaki J, Yoshita M, Yamada M.
-
Cerebrospinal fluid biomarkers of Alzheimer's disease are associated with carotid plaque score and hemodynamics in intra- and extra-cranial arteries on ultrasonography. J Clin Neurosci 2018; 39(2): 321-328.
Kouzuki M, Nagano M, Suzuki T, Katsumata Y, Nakamura S, Takamura A, Urakami K.
-
Comparison of olfactory and gustatory disorders in Alzheimer's disease. Neurol Sci 2018; 49: 32-36.
Kouzuki M, Suzuki T, Nagano M, Nakamura S, Katsumata Y, Takamura A, Urakami K.
-
Randomized double-blind placebo- controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease. Geriatr Gerontol Int 2017; 17(2): 211-218.
Furukawa K, Tomita N, Uematsu D, Okahara K, Shimada H, Ikeda M, Matsui T, Kozaki K, Fujii M, Ogawa T, Umegaki H, Urakami K, Nomura H, Kobayashi N, Nakanishi A, Washimi Y, Yonezawa H, Takahashi S, Kubota M, Wakutani Y, Ito D, Sasaki T, Matsubara E, Une K, Ishiki A, Yahagi Y, Shoji M, Sato H, Terayama Y, Kuzuya M, Araki N, Kodama M, Yamaguchi T, Arai H.
-
Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study. PLoS One 2015; 10(3): e0120540.
Yoshita M, Arai H, Arai H, Arai T, Asada T, Fujishiro H, Hanyu H, Iizuka O, Iseki E, Kashihara K, Kosaka K, Maruno H, Mizukami K, Mizuno Y, Mori E, Nakajima K, Nakamura H, Nakano S, Nakashima K, Nishino Y, Orimo S, Samuraki M, Takahashi A, Taki J, Tokuda T, Urakami K, Utsumi K, Wada K, Washimi Y, Yamasaki J, Yamashina S, Yamada M.
-
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study. Alzheimers Dement 2015; 11(11): 1306-1315.
Ewers M, Mattsson N, Minthod L, Molinuevo JL, Antonell A, Poppg J, Jessen F, Herukka SK, Soininen H, Maetzlerj W, Leyhe T, Burger K, Taniguchi M, Urakami K, Listan S, Dubois B, Blennow K, Hampel H.
-
The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease. Psychogeriatrics 2013; 13(2): 63-70.
Kouzuki M, Asaina F, Taniguchi M, Musha T, Urakami K.
-
Evaluation of dementia-prevention classes for community-dwelling older adults with mild cognitive impairment. Psychogeriatrics 2012; 12(1): 3-10.
Ito Y, Urakami K.
-
Specific feature of olfactory dysfunction with Alzheimer’s disease inspected by the Odor Stick ldentification Test. Psychogeriatrics 2011; 11(4): 196-204.
Jimbo D, Inoue M, Taniguchi M, Urakami K.
-
Touch Panel-type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer’s disease. Psychogeriatrics 2011; 11(1): 28-33.
Inoue M, Jimbo D, Taniguchi M, Urakami K.
-
Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics 2009; 9(4): 173-179.
Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K.
-
AB2 is not associated with late-onset Alzheimer’s disease in Japanese. European J Human Gentics 2009; 17(5): 682-686.
Miyashita A, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Toyabe S, Akazawa K, Kanazawa I, Ihara Y, Kuwano R.
-
Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics 2009; 93(5): 441-448.
Takei N, Miyashita A, Tsukie T, Arai H, Asada T, Imagawa M, Shoji M, Higuchi S, Urakami K, Kimura H, Kakita A, Takahashi H, Tsuji S, Kanazawa I, Ihara Y, Odani S, Kuwano R.
-
Development and evaluation of a computerized test battery for Alzheimer’s disease screening in community-based setting. Am J Alzheimers Dis Other Demen 2009; 24(2): 129-135.
Inoue M, Jinbo D, Nakamura Y, Taniguchi M, Urakami K.
-
Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 26(2): 117-122.
Taniguchi M, Okayama Y, Hashimoto Y, Kitaura M, Jimbo D, Wakutani Y, Wada-Isoe K, Nakashima K, Akatsu H, Furukawa K, Arai H, Urakami K.
-
高齢者が在宅生活継続するための支援に関する検討~在宅高齢者と施設入居者の比較を通して~. 米子医学雑誌 2011; 62(1): 44-51.
福田敏秀, 浦上克哉.
-
要支援高齢者の在宅継続支援の要因に関する研究~タッチパネル式認知機能評価法(TDAS)の有用性~. 米子医学雑誌 2011; 61(6): 131-141.
福田敏秀, 浦上克哉.
-
女性認知症高齢者へのアロマを用いた化粧療法. 老年精神医学雑誌 2011; 22(7): 850-855.
中原淑恵, 足立典子, 片平志保, 阿部美沙子, 竹田伸也, 浦上克哉, 最上多美子.
-
高度アルツハイマー病患者に対するアロマセラピーの有用性. Journal of Japanese Society of Aromatherapy 2008; 7(1): 43-48.
神保太樹, 浦上克哉.
-
香り提示による感覚刺激と認知症の治療効果. Aroma Research 2007; 8(2): 17-23.
神保太樹, 浦上克哉.
-
アルツハイマー病患者に対するアロマセラピーの有用性. Dementia Japan 2005; 19(1): 77-85.
木村有希, 綱分信二, 谷口美也子, 齋藤潤, 北浦美貴, 細田理恵子, 米原あき, 長谷川順子, 児山憲恵, 清水百合子, 森本靖子, 頼田孝男,小嶋良平, 浦上克哉.